返回
Evaluating emerging issues in epidemiology
DOI:10.1016/j.yrtph.2007.04.002.png)
摘要
En 中文
Industry and government institutions need a credible approach for evaluating and responding to emerging public health issues. Representatives of industry, government, and academia met under the auspices of the International Life Sciences Institute's Health and Environmental Sciences Institute (HESI) to develop successful strategies for dealing with emerging issues based on historical case studies. The case studies chosen for evaluation were (1) tampon use and toxic shock syndrome; (2) hazardous waste and childhood cancer risk in Toms River, New Jersey; (3) fenfluramine and phentermine use and valvular heart disease; (4) silicone breast implants and cancer and auto-immune disease; and (5) progestational drugs and birth defects. We identified eight lessons from these case studies. Foremost, we recommend that public and private institutions not defer action until an issue is scientifically resolved and stress that cooperation among issue stakeholders is critical for effective issue resolution. We suggest establishing a research program as an effective way to assure that good science is included in resolution of the issue. We further recommend frequent and timely communication with all stakeholders, and the development of research approaches to fill gaps when the scientific data on an issue are limited. (c) 2007 Elsevier Inc. All rights reserved.
Keyword:
causality
epidemiology
evidence
policy
risk assessment
risk communication
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.5
论文数:
4.7K
被引数:
1.0W
机构
暂无机构信息
引用论文
Review and perspective on ferroelectric HfO2-based thin films for memory applications铁电HfO2-based薄膜在存储器中的应用
Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample
Rheumatology
IF0

